Medical device directive: preparing for the amendments
1Donawa and Associates Ltd, Rome, Italy. donawa@srd.it
Abstract:
Article 21 of the In Vitro Diagnostic (IVD) Directive (98/79/EC) contains several important amendments to the Medical Device (MD) Directive (93/42/EEC). This is generally well known. However, the amendments are not always being kept in mind when discussing the requirements of the MD Directive. This article reviews the more important amendments and suggests that it is time to begin planning for them. The new definition of IVD products is also provided.
Related Concept Videos
FDA Approved Drugs: Changes to Approved Drugs
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...

